A new study published in JAMA Psychiatry suggests that a swallowable vibrating capsule may provide a novel way to identify people recovering from anorexia nervosa who remain at higher risk of relapse. Researchers from UCLA used the capsule to investigate interoception, the process by which the brain senses and interprets signals originating from inside the body. Because anorexia nervosa is associated not only with eating behaviors but also with altered perception of hunger, fullness and other bodily sensations, the researchers wanted to determine whether persistent disruptions in gut-brain communication could help explain why relapse remains common even after weight restoration.
The study enrolled 62 women and girls with weight-restored restrictive anorexia nervosa and 57 healthy control participants. After swallowing the capsule, participants experienced periods of gentle vibrations within the stomach and surrounding gastrointestinal tract and were asked to indicate when they detected the sensation. Researchers simultaneously monitored brain activity using EEG and collected additional physiological and behavioral data. The results showed that participants with anorexia were significantly less accurate at detecting lower-intensity gut sensations compared with healthy controls, suggesting lingering differences in how internal bodily signals are processed. When stronger vibrations were delivered, performance between the two groups became more similar.
Researchers also applied computational modeling techniques to better understand how participants interpreted and responded to the signals. The analysis suggested that individuals recovering from anorexia were more likely to expect that bodily sensations would not occur and differed in how they updated those expectations when new information was presented. These findings point to ongoing alterations in predictive processing and body awareness that may persist even after physical recovery and weight normalization. According to the investigators, this challenges the idea that recovery is solely a matter of restoring body weight and highlights the importance of addressing underlying neurological and physiological mechanisms.
The study’s follow-up findings were particularly notable. Participants with anorexia were monitored remotely for six months after completing the experiment, and a significant number experienced a full relapse. Several measures captured during the capsule task—including how participants anticipated gut sensations, their response patterns and how unpleasant they found the sensations—were associated with relapse risk and eating disorder symptom severity. While the researchers emphasize that the capsule is not intended as a diagnostic or therapeutic tool, they believe the technology could eventually help clinicians identify individuals who may need additional support during recovery and provide a more objective way to monitor treatment progress.
The vibrating capsule used in the study was originally developed for gastrointestinal applications and served only as a controlled method for stimulating gut sensations. However, the work highlights a broader trend toward using ingestible and digital health technologies to measure biological signals that were previously difficult to assess. If validated in larger and more diverse populations, similar approaches could help move eating disorder care beyond symptom observation and toward more personalized, biologically informed treatment strategies.
Click here to read the original news story.